By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Topical steroids > Flurandrenolide topical > Flurandrenolide Topical Dosage
Topical steroids
https://themeditary.com/dosage-information/flurandrenolide-topical-dosage-11295.html

Flurandrenolide Topical Dosage

Drug Detail:Flurandrenolide topical (Flurandrenolide topical [ flur-an-dren-oh-lide ])

Drug Class: Topical steroids

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Dermatitis

Cream, ointment, lotion: Apply a thin film topically to the affected area(s) 2 to 3 times a day
Tape: Apply every 12 to 24 hours or as directed to clean, dry skin that is free of hair

Comments:

  • For the management of psoriasis or recalcitrant conditions, occlusive dressings may be used.
  • Tape should be replaced every 12 to 24 hours to reduce adverse reactions.
  • Tape should always be cut, never torn.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions

Usual Adult Dose for Eczema

Cream, ointment, lotion: Apply a thin film topically to the affected area(s) 2 to 3 times a day
Tape: Apply every 12 to 24 hours or as directed to clean, dry skin that is free of hair

Comments:

  • For the management of psoriasis or recalcitrant conditions, occlusive dressings may be used.
  • Tape should be replaced every 12 to 24 hours to reduce adverse reactions.
  • Tape should always be cut, never torn.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions

Usual Adult Dose for Psoriasis

Cream, ointment, lotion: Apply a thin film topically to the affected area(s) 2 to 3 times a day
Tape: Apply every 12 to 24 hours or as directed to clean, dry skin that is free of hair

Comments:

  • For the management of psoriasis or recalcitrant conditions, occlusive dressings may be used.
  • Tape should be replaced every 12 to 24 hours to reduce adverse reactions.
  • Tape should always be cut, never torn.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions

Usual Pediatric Dose for Dermatitis

Cream, ointment, lotion: Apply a thin film topically to the affected area(s) 2 to 3 times a day
Tape: Apply every 12 to 24 hours or as directed to clean, dry skin that is free of hair

Comments:

  • For the management of psoriasis or recalcitrant conditions, occlusive dressings may be used.
  • Tape should be replaced every 12 to 24 hours to reduce adverse reactions.
  • Tape should always be cut, never torn.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions

Usual Pediatric Dose for Eczema

Cream, ointment, lotion: Apply a thin film topically to the affected area(s) 2 to 3 times a day
Tape: Apply every 12 to 24 hours or as directed to clean, dry skin that is free of hair

Comments:

  • For the management of psoriasis or recalcitrant conditions, occlusive dressings may be used.
  • Tape should be replaced every 12 to 24 hours to reduce adverse reactions.
  • Tape should always be cut, never torn.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions

Usual Pediatric Dose for Psoriasis

Cream, ointment, lotion: Apply a thin film topically to the affected area(s) 2 to 3 times a day
Tape: Apply every 12 to 24 hours or as directed to clean, dry skin that is free of hair

Comments:

  • For the management of psoriasis or recalcitrant conditions, occlusive dressings may be used.
  • Tape should be replaced every 12 to 24 hours to reduce adverse reactions.
  • Tape should always be cut, never torn.

Uses: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, particularly dry, scaling localized lesions

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Pediatric: Children may absorb proportionally larger amounts after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing's syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Rub in gently and completely
  • Administration of topical corticosteroids to pediatric patients should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of pediatric patients.
  • If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.

Monitoring:
  • Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)
  • Patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression.
  • If used on the face, courses should be limited to five days and occlusion should not be used.
  • In the presence of skin infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur, this drug should be discontinued until the infection has been adequately controlled.

Patient advice:
  • This drug is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes, face, underarms, or groin areas.
  • If no improvement is seen within 2 weeks, patients should contact their healthcare provider.
  • Patients should be advised not to use this medication for any disorder other than that for which it was prescribed.
  • The treated skin area should not be bandaged or otherwise covered or wrapped unless directed to do so by the physician.
  • Patients should report any signs of local adverse reactions, especially under occlusive dressings.
  • Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a patient being treated in the diaper area, because these garments may constitute occlusive dressings.
  • Do not use other corticosteroid-containing products while using this drug without first consulting a physician.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by